NCT03646747 Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response. Status UNKNOWN Phase NA
NCT03646461 Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC Status TERMINATED Phase PHASE2
NCT03640195 Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy Status COMPLETED Phase NA
NCT03637335 Comparing Palliative Radiotherapy With or Without Carboplatin Status TERMINATED Phase PHASE3
NCT03632200 Nutritional Course of Care After Surgical Treatment at the Patients Affected by a Cancer of the Head and by the Neck Status RECRUITING Phase NA
NCT03631017 Imaging With a PET Agent for Detection of Cancers of the Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03607227 Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery Status COMPLETED Phase PHASE4
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Status COMPLETED Phase PHASE1/PHASE2
NCT03578432 Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy Status TERMINATED Phase EARLY_PHASE1
NCT03565003 A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China Status COMPLETED Phase PHASE1/PHASE2
NCT03550053 A 3D Analysis of Mandibular Plating Strategies in Oromandibular Reconstruction. Status COMPLETED Phase NA
NCT03548727 Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT Status WITHDRAWN Phase EARLY_PHASE1
NCT03543813 PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL Status COMPLETED Phase PHASE1/PHASE2
NCT03539198 Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer Status TERMINATED Phase N/A
NCT03539172 Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study Status UNKNOWN Phase PHASE2
NCT03534778 Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study Status UNKNOWN Phase N/A
NCT03531190 Pre- and Postoperative Nutrition in Head and Neck Cancer Patients Status COMPLETED Phase NA
NCT03524755 Physical Exercise for Patients Who Suffer From Weight Loss Due to Head and Neck Cancer Undergoing Medical Treatment Status COMPLETED Phase NA
NCT03524326 Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03518606 Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1/PHASE2